

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fatty acid elongation (GO:0030497) | 8.37223692 |
| 2 | cellular potassium ion homeostasis (GO:0030007) | 6.15353549 |
| 3 | long-chain fatty acid biosynthetic process (GO:0042759) | 5.80704960 |
| 4 | myelination (GO:0042552) | 5.73232433 |
| 5 | amyloid precursor protein metabolic process (GO:0042982) | 5.72600642 |
| 6 | cholesterol biosynthetic process (GO:0006695) | 5.65786536 |
| 7 | ensheathment of neurons (GO:0007272) | 5.65245931 |
| 8 | axon ensheathment (GO:0008366) | 5.65245931 |
| 9 | sodium ion export (GO:0071436) | 5.57388039 |
| 10 | L-amino acid import (GO:0043092) | 5.41917466 |
| 11 | postsynaptic membrane organization (GO:0001941) | 5.38536020 |
| 12 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.28054100 |
| 13 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 5.12190841 |
| 14 | sterol biosynthetic process (GO:0016126) | 5.09750436 |
| 15 | synaptic vesicle exocytosis (GO:0016079) | 4.98975918 |
| 16 | glutamate secretion (GO:0014047) | 4.96155986 |
| 17 | regulation of lipoprotein metabolic process (GO:0050746) | 4.79785004 |
| 18 | negative regulation of protein localization to cell surface (GO:2000009) | 4.74585785 |
| 19 | myelin maintenance (GO:0043217) | 4.70708253 |
| 20 | negative regulation of neurotransmitter transport (GO:0051589) | 4.68503710 |
| 21 | potassium ion homeostasis (GO:0055075) | 4.62420363 |
| 22 | establishment of mitochondrion localization (GO:0051654) | 4.57118076 |
| 23 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.55349649 |
| 24 | amino acid import (GO:0043090) | 4.50222596 |
| 25 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 4.47454185 |
| 26 | cerebellar granule cell differentiation (GO:0021707) | 4.39447707 |
| 27 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.35381369 |
| 28 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.30176486 |
| 29 | isoprenoid biosynthetic process (GO:0008299) | 4.30089619 |
| 30 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.23750413 |
| 31 | neuronal ion channel clustering (GO:0045161) | 4.20837540 |
| 32 | regulation of collateral sprouting (GO:0048670) | 4.12543757 |
| 33 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.05419110 |
| 34 | regulation of synaptic vesicle transport (GO:1902803) | 4.02111948 |
| 35 | auditory behavior (GO:0031223) | 3.95523819 |
| 36 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.94052569 |
| 37 | neurotransmitter uptake (GO:0001504) | 3.92850438 |
| 38 | neurotransmitter secretion (GO:0007269) | 3.89715826 |
| 39 | cellular sodium ion homeostasis (GO:0006883) | 3.88433308 |
| 40 | vocalization behavior (GO:0071625) | 3.86847983 |
| 41 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.85136366 |
| 42 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.81729153 |
| 43 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.81342424 |
| 44 | neuronal action potential propagation (GO:0019227) | 3.76997891 |
| 45 | synaptic transmission, glutamatergic (GO:0035249) | 3.75281637 |
| 46 | very long-chain fatty acid metabolic process (GO:0000038) | 3.74870354 |
| 47 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.68855469 |
| 48 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 3.63965107 |
| 49 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 3.63965107 |
| 50 | regulation of synapse structural plasticity (GO:0051823) | 3.60524362 |
| 51 | exploration behavior (GO:0035640) | 3.59820983 |
| 52 | import into cell (GO:0098657) | 3.58964321 |
| 53 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.57449844 |
| 54 | * regulation of neuronal synaptic plasticity (GO:0048168) | 3.56018221 |
| 55 | eye photoreceptor cell differentiation (GO:0001754) | 3.51892242 |
| 56 | photoreceptor cell differentiation (GO:0046530) | 3.51892242 |
| 57 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.48344891 |
| 58 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.47864343 |
| 59 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.44354876 |
| 60 | response to auditory stimulus (GO:0010996) | 3.43715516 |
| 61 | axon development (GO:0061564) | 3.41267352 |
| 62 | cell communication by electrical coupling (GO:0010644) | 3.40942852 |
| 63 | glycerophospholipid catabolic process (GO:0046475) | 3.40120318 |
| 64 | glutamate receptor signaling pathway (GO:0007215) | 3.40066685 |
| 65 | response to redox state (GO:0051775) | 3.38396766 |
| 66 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.38320296 |
| 67 | positive regulation of dendritic spine development (GO:0060999) | 3.36024135 |
| 68 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.36011543 |
| 69 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.35326793 |
| 70 | substantia nigra development (GO:0021762) | 3.35132959 |
| 71 | neurotransmitter transport (GO:0006836) | 3.34635745 |
| 72 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.32329732 |
| 73 | response to lipoprotein particle (GO:0055094) | 3.31152778 |
| 74 | neuron-neuron synaptic transmission (GO:0007270) | 3.28999884 |
| 75 | gamma-aminobutyric acid transport (GO:0015812) | 3.27629002 |
| 76 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.26601597 |
| 77 | cerebellar Purkinje cell layer development (GO:0021680) | 3.26578719 |
| 78 | regulation of neurotransmitter levels (GO:0001505) | 3.22736244 |
| 79 | mechanosensory behavior (GO:0007638) | 3.19120836 |
| 80 | amyloid precursor protein catabolic process (GO:0042987) | 3.19104613 |
| 81 | neuromuscular process controlling balance (GO:0050885) | 3.18820768 |
| 82 | positive regulation of synapse maturation (GO:0090129) | 3.15989899 |
| 83 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.15688633 |
| 84 | thioester biosynthetic process (GO:0035384) | 3.14864761 |
| 85 | acyl-CoA biosynthetic process (GO:0071616) | 3.14864761 |
| 86 | regulation of neurotransmitter secretion (GO:0046928) | 3.13176287 |
| 87 | detection of temperature stimulus (GO:0016048) | 3.12828677 |
| 88 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.11793151 |
| 89 | regulation of neurotransmitter transport (GO:0051588) | 3.11258242 |
| 90 | protein palmitoylation (GO:0018345) | 3.10930027 |
| 91 | protein localization to synapse (GO:0035418) | 3.10855832 |
| 92 | magnesium ion transport (GO:0015693) | 3.09121996 |
| 93 | protein neddylation (GO:0045116) | 3.08188507 |
| 94 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.07796228 |
| 95 | adult walking behavior (GO:0007628) | 3.06400142 |
| 96 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.02167346 |
| 97 | * regulation of synaptic plasticity (GO:0048167) | 3.00204717 |
| 98 | presynaptic membrane organization (GO:0097090) | 2.99943544 |
| 99 | creatine metabolic process (GO:0006600) | 2.98720619 |
| 100 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.98547617 |
| 101 | regulation of dendritic spine development (GO:0060998) | 2.97347464 |
| 102 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.97032989 |
| 103 | C4-dicarboxylate transport (GO:0015740) | 2.96298637 |
| 104 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.94821776 |
| 105 | regulation of ARF protein signal transduction (GO:0032012) | 2.93546384 |
| 106 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.92217782 |
| 107 | synaptic vesicle endocytosis (GO:0048488) | 2.91755538 |
| 108 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.91443422 |
| 109 | synaptic vesicle maturation (GO:0016188) | 2.90975581 |
| 110 | L-glutamate transport (GO:0015813) | 2.90909283 |
| 111 | long-term memory (GO:0007616) | 2.89475371 |
| 112 | myelination in peripheral nervous system (GO:0022011) | 2.88449042 |
| 113 | peripheral nervous system axon ensheathment (GO:0032292) | 2.88449042 |
| 114 | positive regulation of membrane potential (GO:0045838) | 2.88322180 |
| 115 | extracellular matrix assembly (GO:0085029) | 2.88288460 |
| 116 | acidic amino acid transport (GO:0015800) | 2.87580974 |
| 117 | membrane tubulation (GO:0097320) | 2.87578501 |
| 118 | astrocyte development (GO:0014002) | 2.86471405 |
| 119 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.85348434 |
| 120 | regulation of postsynaptic membrane potential (GO:0060078) | 2.84772410 |
| 121 | tissue regeneration (GO:0042246) | 2.84053569 |
| 122 | membrane assembly (GO:0071709) | 2.81701013 |
| 123 | glycine transport (GO:0015816) | 2.81132171 |
| 124 | detection of calcium ion (GO:0005513) | 2.81047321 |
| 125 | neuron cell-cell adhesion (GO:0007158) | 2.79399934 |
| 126 | dendritic spine morphogenesis (GO:0060997) | 2.78875975 |
| 127 | membrane depolarization during action potential (GO:0086010) | 2.77200153 |
| 128 | oligodendrocyte differentiation (GO:0048709) | 2.76081461 |
| 129 | * long-term synaptic potentiation (GO:0060291) | 2.75942852 |
| 130 | * response to methylmercury (GO:0051597) | 2.75532855 |
| 131 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.75010376 |
| 132 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.74587141 |
| 133 | * regulation of synaptic transmission (GO:0050804) | 2.74164241 |
| 134 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.73721470 |
| 135 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.73141813 |
| 136 | positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745) | 2.71127456 |
| 137 | neuron remodeling (GO:0016322) | 2.70392972 |
| 138 | regulation of sensory perception (GO:0051931) | 2.69847356 |
| 139 | regulation of sensory perception of pain (GO:0051930) | 2.69847356 |
| 140 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 2.68034873 |
| 141 | negative regulation of axonogenesis (GO:0050771) | 2.67396322 |
| 142 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.67019208 |
| 143 | iron coordination entity transport (GO:1901678) | 2.66683137 |
| 144 | apical protein localization (GO:0045176) | 2.65921706 |
| 145 | nerve growth factor signaling pathway (GO:0038180) | 2.65692559 |
| 146 | coenzyme catabolic process (GO:0009109) | 2.64243537 |
| 147 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.63554988 |
| 148 | alcohol biosynthetic process (GO:0046165) | 2.59041343 |
| 149 | glycosylceramide metabolic process (GO:0006677) | 2.58923810 |
| 150 | transmission of nerve impulse (GO:0019226) | 2.57538879 |
| 151 | asymmetric protein localization (GO:0008105) | 2.56492783 |
| 152 | presynaptic membrane assembly (GO:0097105) | 2.55930415 |
| 153 | cranial nerve development (GO:0021545) | 2.53326358 |
| 154 | locomotory exploration behavior (GO:0035641) | 2.49430392 |
| 155 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.48739354 |
| 156 | estrogen biosynthetic process (GO:0006703) | 2.46777101 |
| 157 | potassium ion import (GO:0010107) | 2.45447204 |
| 158 | response to dietary excess (GO:0002021) | 2.44938635 |
| 159 | regulation of beta-amyloid formation (GO:1902003) | 2.44502747 |
| 160 | regulation of neurotransmitter uptake (GO:0051580) | 2.43250797 |
| 161 | neuron recognition (GO:0008038) | 2.42369555 |
| 162 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.41175444 |
| 163 | peripheral nervous system development (GO:0007422) | 2.40222967 |
| 164 | negative regulation of axon extension (GO:0030517) | 2.38438363 |
| 165 | negative regulation of chemokine production (GO:0032682) | 2.36985548 |
| 166 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.36718370 |
| 167 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.36249517 |
| 168 | limb bud formation (GO:0060174) | 2.35318176 |
| 169 | neuron projection regeneration (GO:0031102) | 2.33895823 |
| 170 | central nervous system myelination (GO:0022010) | 10.5320533 |
| 171 | axon ensheathment in central nervous system (GO:0032291) | 10.5320533 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.64653654 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.73531882 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.56598076 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.52419127 |
| 5 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.50810603 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.42762628 |
| 7 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.20787577 |
| 8 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.18883710 |
| 9 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.14717171 |
| 10 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.14425559 |
| 11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.12013330 |
| 12 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.12013330 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.08852179 |
| 14 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.08220312 |
| 15 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.07786265 |
| 16 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.06141256 |
| 17 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.05762313 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.03974009 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.02048453 |
| 20 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.95575357 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.93152885 |
| 22 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.86778289 |
| 23 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.84398131 |
| 24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.82307308 |
| 25 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.80290636 |
| 26 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.77142786 |
| 27 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.72930547 |
| 28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.70904574 |
| 29 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.63658346 |
| 30 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.61597858 |
| 31 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.60057715 |
| 32 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.51281108 |
| 33 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.45334009 |
| 34 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.44212413 |
| 35 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.41853292 |
| 36 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.41670839 |
| 37 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.40649337 |
| 38 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.40092787 |
| 39 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.39112086 |
| 40 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.37884413 |
| 41 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.36545456 |
| 42 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.36533398 |
| 43 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.36279263 |
| 44 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.36033272 |
| 45 | P300_19829295_ChIP-Seq_ESCs_Human | 1.35913557 |
| 46 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.34060770 |
| 47 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.33871110 |
| 48 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.33833111 |
| 49 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.32880337 |
| 50 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.30128419 |
| 51 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.28890003 |
| 52 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.28604741 |
| 53 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28062696 |
| 54 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.27516153 |
| 55 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.26969477 |
| 56 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.25820500 |
| 57 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.25820500 |
| 58 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.23022883 |
| 59 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.22681092 |
| 60 | STAT3_23295773_ChIP-Seq_U87_Human | 1.22428809 |
| 61 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.22075938 |
| 62 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.20686010 |
| 63 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.20265629 |
| 64 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.17271163 |
| 65 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.17146298 |
| 66 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.16384475 |
| 67 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.15798314 |
| 68 | VDR_22108803_ChIP-Seq_LS180_Human | 1.15199687 |
| 69 | AR_19668381_ChIP-Seq_PC3_Human | 1.14994775 |
| 70 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.14807837 |
| 71 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.14689039 |
| 72 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.13663421 |
| 73 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.13318969 |
| 74 | TP53_16413492_ChIP-PET_HCT116_Human | 1.13279919 |
| 75 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.12723209 |
| 76 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.11838808 |
| 77 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.11585585 |
| 78 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.10645236 |
| 79 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.10598141 |
| 80 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.10325684 |
| 81 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.10035247 |
| 82 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.09831032 |
| 83 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.09479047 |
| 84 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09107547 |
| 85 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.08904200 |
| 86 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.08189637 |
| 87 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.07912270 |
| 88 | KDM2B_26808549_Chip-Seq_K562_Human | 1.07065309 |
| 89 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.05971324 |
| 90 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.05434827 |
| 91 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05111144 |
| 92 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.04526487 |
| 93 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.03707665 |
| 94 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.03707665 |
| 95 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.02408001 |
| 96 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.02251203 |
| 97 | TCF4_23295773_ChIP-Seq_U87_Human | 1.01983209 |
| 98 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.01000643 |
| 99 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.00965318 |
| 100 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.00963871 |
| 101 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.00917823 |
| 102 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.00486442 |
| 103 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.00384750 |
| 104 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.99993212 |
| 105 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.99845524 |
| 106 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.98981495 |
| 107 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.98254351 |
| 108 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.98172033 |
| 109 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.97814569 |
| 110 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.97739278 |
| 111 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97069175 |
| 112 | FUS_26573619_Chip-Seq_HEK293_Human | 0.96730063 |
| 113 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.95663796 |
| 114 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.94591229 |
| 115 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.93703420 |
| 116 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.93349555 |
| 117 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.93285460 |
| 118 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92740522 |
| 119 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.92130535 |
| 120 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.91647225 |
| 121 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.91515363 |
| 122 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.90396382 |
| 123 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.90053612 |
| 124 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89551097 |
| 125 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.89241415 |
| 126 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.89204031 |
| 127 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.88880297 |
| 128 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.88800875 |
| 129 | AR_25329375_ChIP-Seq_VCAP_Human | 0.88782198 |
| 130 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.88005402 |
| 131 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.87833672 |
| 132 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.87645407 |
| 133 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.86894271 |
| 134 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.86350745 |
| 135 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.84093805 |
| 136 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.83646211 |
| 137 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.83615169 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 4.73028132 |
| 2 | MP0003880_abnormal_central_pattern | 3.61383482 |
| 3 | MP0003690_abnormal_glial_cell | 3.05495170 |
| 4 | MP0004270_analgesia | 3.04375172 |
| 5 | MP0003329_amyloid_beta_deposits | 3.04194551 |
| 6 | MP0002272_abnormal_nervous_system | 2.77956941 |
| 7 | MP0005423_abnormal_somatic_nervous | 2.60348302 |
| 8 | MP0004859_abnormal_synaptic_plasticity | 2.58743150 |
| 9 | MP0004742_abnormal_vestibular_system | 2.56704537 |
| 10 | MP0003950_abnormal_plasma_membrane | 2.51724958 |
| 11 | MP0001486_abnormal_startle_reflex | 2.51061426 |
| 12 | MP0002064_seizures | 2.45806792 |
| 13 | MP0001905_abnormal_dopamine_level | 2.40949832 |
| 14 | MP0004142_abnormal_muscle_tone | 2.36332488 |
| 15 | MP0004885_abnormal_endolymph | 2.30753027 |
| 16 | MP0003136_yellow_coat_color | 2.23463784 |
| 17 | MP0001984_abnormal_olfaction | 2.21714832 |
| 18 | MP0003635_abnormal_synaptic_transmissio | 2.20507847 |
| 19 | MP0003634_abnormal_glial_cell | 2.19306338 |
| 20 | MP0001529_abnormal_vocalization | 2.18620396 |
| 21 | MP0009046_muscle_twitch | 2.14972513 |
| 22 | MP0005171_absent_coat_pigmentation | 2.10973948 |
| 23 | MP0001485_abnormal_pinna_reflex | 2.03615351 |
| 24 | MP0002734_abnormal_mechanical_nocicepti | 2.02877502 |
| 25 | MP0000778_abnormal_nervous_system | 2.01750564 |
| 26 | MP0009745_abnormal_behavioral_response | 2.00015562 |
| 27 | MP0003633_abnormal_nervous_system | 1.93427015 |
| 28 | MP0003632_abnormal_nervous_system | 1.83795947 |
| 29 | MP0003631_nervous_system_phenotype | 1.83293593 |
| 30 | MP0002063_abnormal_learning/memory/cond | 1.82889318 |
| 31 | MP0004134_abnormal_chest_morphology | 1.81192972 |
| 32 | MP0001968_abnormal_touch/_nociception | 1.80667269 |
| 33 | MP0005409_darkened_coat_color | 1.80343499 |
| 34 | MP0003879_abnormal_hair_cell | 1.76605248 |
| 35 | MP0001440_abnormal_grooming_behavior | 1.74367656 |
| 36 | MP0002572_abnormal_emotion/affect_behav | 1.73826705 |
| 37 | MP0008569_lethality_at_weaning | 1.73665333 |
| 38 | MP0005410_abnormal_fertilization | 1.68088340 |
| 39 | MP0002229_neurodegeneration | 1.67717454 |
| 40 | MP0000569_abnormal_digit_pigmentation | 1.67424120 |
| 41 | MP0005167_abnormal_blood-brain_barrier | 1.67130848 |
| 42 | MP0002736_abnormal_nociception_after | 1.65461575 |
| 43 | MP0000604_amyloidosis | 1.63338885 |
| 44 | MP0002067_abnormal_sensory_capabilities | 1.58623116 |
| 45 | MP0002735_abnormal_chemical_nociception | 1.57644948 |
| 46 | MP0000955_abnormal_spinal_cord | 1.53122761 |
| 47 | MP0002733_abnormal_thermal_nociception | 1.51246545 |
| 48 | * MP0001970_abnormal_pain_threshold | 1.50457419 |
| 49 | MP0002638_abnormal_pupillary_reflex | 1.44851190 |
| 50 | MP0005623_abnormal_meninges_morphology | 1.43748558 |
| 51 | MP0004043_abnormal_pH_regulation | 1.42802277 |
| 52 | MP0003656_abnormal_erythrocyte_physiolo | 1.42704568 |
| 53 | MP0002882_abnormal_neuron_morphology | 1.38600029 |
| 54 | MP0000462_abnormal_digestive_system | 1.36644684 |
| 55 | MP0005551_abnormal_eye_electrophysiolog | 1.32869939 |
| 56 | MP0004145_abnormal_muscle_electrophysio | 1.31787202 |
| 57 | MP0002066_abnormal_motor_capabilities/c | 1.31536032 |
| 58 | MP0010678_abnormal_skin_adnexa | 1.29164995 |
| 59 | MP0001963_abnormal_hearing_physiology | 1.25145007 |
| 60 | MP0008260_abnormal_autophagy | 1.25068809 |
| 61 | MP0003806_abnormal_nucleotide_metabolis | 1.19391963 |
| 62 | MP0004858_abnormal_nervous_system | 1.17045595 |
| 63 | MP0002909_abnormal_adrenal_gland | 1.11299391 |
| 64 | MP0001299_abnormal_eye_distance/ | 1.10375538 |
| 65 | MP0006276_abnormal_autonomic_nervous | 1.10327035 |
| 66 | MP0002752_abnormal_somatic_nervous | 1.09588503 |
| 67 | MP0005386_behavior/neurological_phenoty | 1.08174092 |
| 68 | MP0004924_abnormal_behavior | 1.08174092 |
| 69 | MP0000747_muscle_weakness | 1.03232738 |
| 70 | MP0003787_abnormal_imprinting | 1.03176806 |
| 71 | MP0003195_calcinosis | 1.02488168 |
| 72 | MP0001177_atelectasis | 1.02094455 |
| 73 | MP0002184_abnormal_innervation | 1.01918205 |
| 74 | MP0001501_abnormal_sleep_pattern | 1.01704359 |
| 75 | MP0002557_abnormal_social/conspecific_i | 0.98877102 |
| 76 | MP0001986_abnormal_taste_sensitivity | 0.98118791 |
| 77 | MP0000372_irregular_coat_pigmentation | 0.97124656 |
| 78 | MP0002822_catalepsy | 0.96902208 |
| 79 | MP0000383_abnormal_hair_follicle | 0.96424381 |
| 80 | MP0005174_abnormal_tail_pigmentation | 0.95959783 |
| 81 | MP0002295_abnormal_pulmonary_circulatio | 0.94354295 |
| 82 | MP0005058_abnormal_lysosome_morphology | 0.93651792 |
| 83 | MP0002653_abnormal_ependyma_morphology | 0.92369807 |
| 84 | MP0004381_abnormal_hair_follicle | 0.88019427 |
| 85 | MP0002095_abnormal_skin_pigmentation | 0.87816896 |
| 86 | MP0005646_abnormal_pituitary_gland | 0.87792504 |
| 87 | MP0005195_abnormal_posterior_eye | 0.83257360 |
| 88 | MP0002152_abnormal_brain_morphology | 0.82411707 |
| 89 | MP0000749_muscle_degeneration | 0.82148281 |
| 90 | MP0000015_abnormal_ear_pigmentation | 0.80408916 |
| 91 | MP0003938_abnormal_ear_development | 0.78838987 |
| 92 | MP0003075_altered_response_to | 0.78819155 |
| 93 | MP0004811_abnormal_neuron_physiology | 0.78739423 |
| 94 | MP0005253_abnormal_eye_physiology | 0.78362169 |
| 95 | MP0009250_abnormal_appendicular_skeleto | 0.77012656 |
| 96 | MP0008874_decreased_physiological_sensi | 0.75760099 |
| 97 | MP0000026_abnormal_inner_ear | 0.75475031 |
| 98 | MP0001851_eye_inflammation | 0.73722071 |
| 99 | MP0004036_abnormal_muscle_relaxation | 0.73616401 |
| 100 | MP0004130_abnormal_muscle_cell | 0.73026887 |
| 101 | MP0000647_abnormal_sebaceous_gland | 0.72976363 |
| 102 | MP0003172_abnormal_lysosome_physiology | 0.72541249 |
| 103 | MP0000762_abnormal_tongue_morphology | 0.71395280 |
| 104 | MP0005535_abnormal_body_temperature | 0.70813334 |
| 105 | MP0005388_respiratory_system_phenotype | 0.68658547 |
| 106 | MP0002133_abnormal_respiratory_system | 0.68658547 |
| 107 | MP0004215_abnormal_myocardial_fiber | 0.65447640 |
| 108 | MP0009780_abnormal_chondrocyte_physiolo | 0.65316212 |
| 109 | MP0003137_abnormal_impulse_conducting | 0.63811712 |
| 110 | MP0005645_abnormal_hypothalamus_physiol | 0.63672011 |
| 111 | MP0002090_abnormal_vision | 0.63161475 |
| 112 | MP0003122_maternal_imprinting | 0.62681321 |
| 113 | MP0004147_increased_porphyrin_level | 0.60473319 |
| 114 | MP0002069_abnormal_eating/drinking_beha | 0.60448047 |
| 115 | MP0001502_abnormal_circadian_rhythm | 0.60141244 |
| 116 | MP0005670_abnormal_white_adipose | 0.58767711 |
| 117 | MP0001943_abnormal_respiration | 0.58610003 |
| 118 | MP0000579_abnormal_nail_morphology | 0.58457065 |
| 119 | MP0005166_decreased_susceptibility_to | 0.56518869 |
| 120 | MP0005595_abnormal_vascular_smooth | 0.56418624 |
| 121 | MP0005075_abnormal_melanosome_morpholog | 0.48242028 |
| 122 | MP0010386_abnormal_urinary_bladder | 0.47601867 |
| 123 | MP0003011_delayed_dark_adaptation | 0.46328618 |
| 124 | MP0000566_synostosis | 0.44681405 |
| 125 | MP0001958_emphysema | 0.43572736 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 6.49174119 |
| 2 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 6.49174119 |
| 3 | Neurofibrillary tangles (HP:0002185) | 6.32788403 |
| 4 | Abnormality of the corticospinal tract (HP:0002492) | 5.10882648 |
| 5 | Termporal pattern (HP:0011008) | 4.99511486 |
| 6 | Insidious onset (HP:0003587) | 4.99511486 |
| 7 | Diplopia (HP:0000651) | 4.87381787 |
| 8 | Supranuclear gaze palsy (HP:0000605) | 4.59452202 |
| 9 | Cerebral inclusion bodies (HP:0100314) | 4.56161102 |
| 10 | Febrile seizures (HP:0002373) | 4.48718171 |
| 11 | Atonic seizures (HP:0010819) | 4.41526393 |
| 12 | Peripheral hypomyelination (HP:0007182) | 4.22923417 |
| 13 | Hemiplegia (HP:0002301) | 4.11465950 |
| 14 | Parakeratosis (HP:0001036) | 4.03246097 |
| 15 | Retinal dysplasia (HP:0007973) | 3.84320477 |
| 16 | Action tremor (HP:0002345) | 3.78190321 |
| 17 | Onion bulb formation (HP:0003383) | 3.65732060 |
| 18 | Myokymia (HP:0002411) | 3.60791306 |
| 19 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.59614047 |
| 20 | Abnormal eating behavior (HP:0100738) | 3.58801075 |
| 21 | Truncal ataxia (HP:0002078) | 3.57181370 |
| 22 | Generalized tonic-clonic seizures (HP:0002069) | 3.56239318 |
| 23 | Ankle clonus (HP:0011448) | 3.41347961 |
| 24 | Scanning speech (HP:0002168) | 3.40621476 |
| 25 | Abnormality of glycolysis (HP:0004366) | 3.37242077 |
| 26 | Increased serum pyruvate (HP:0003542) | 3.37242077 |
| 27 | Spastic gait (HP:0002064) | 3.33195685 |
| 28 | Dysmetria (HP:0001310) | 3.24035539 |
| 29 | Intention tremor (HP:0002080) | 3.19940764 |
| 30 | Absence seizures (HP:0002121) | 3.13515419 |
| 31 | Dialeptic seizures (HP:0011146) | 3.01928928 |
| 32 | Slow saccadic eye movements (HP:0000514) | 3.00253686 |
| 33 | Pheochromocytoma (HP:0002666) | 2.96394732 |
| 34 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.94734383 |
| 35 | Leukodystrophy (HP:0002415) | 2.93914812 |
| 36 | Postural instability (HP:0002172) | 2.93214347 |
| 37 | White forelock (HP:0002211) | 2.92948062 |
| 38 | Focal motor seizures (HP:0011153) | 2.86629167 |
| 39 | Mutism (HP:0002300) | 2.75629992 |
| 40 | Limb dystonia (HP:0002451) | 2.71145976 |
| 41 | Ulnar claw (HP:0001178) | 2.66209638 |
| 42 | Cerebral hypomyelination (HP:0006808) | 2.63934210 |
| 43 | Neuroendocrine neoplasm (HP:0100634) | 2.63737995 |
| 44 | Visual hallucinations (HP:0002367) | 2.61615532 |
| 45 | Patchy hypopigmentation of hair (HP:0011365) | 2.60551993 |
| 46 | Torticollis (HP:0000473) | 2.59690415 |
| 47 | Obstructive sleep apnea (HP:0002870) | 2.58623618 |
| 48 | Sensory axonal neuropathy (HP:0003390) | 2.56702755 |
| 49 | Urinary urgency (HP:0000012) | 2.56507715 |
| 50 | Cerebral hemorrhage (HP:0001342) | 2.54744580 |
| 51 | Increased circulating renin level (HP:0000848) | 2.51980309 |
| 52 | Tetraplegia (HP:0002445) | 2.51605894 |
| 53 | Akinesia (HP:0002304) | 2.51308984 |
| 54 | Heterochromia iridis (HP:0001100) | 2.48578088 |
| 55 | Axonal loss (HP:0003447) | 2.48060651 |
| 56 | Acute necrotizing encephalopathy (HP:0006965) | 2.42698801 |
| 57 | Lower limb muscle weakness (HP:0007340) | 2.42095931 |
| 58 | Abnormal auditory evoked potentials (HP:0006958) | 2.42003308 |
| 59 | Blue irides (HP:0000635) | 2.41106867 |
| 60 | Delusions (HP:0000746) | 2.39240075 |
| 61 | Rigidity (HP:0002063) | 2.35873099 |
| 62 | Metabolic alkalosis (HP:0200114) | 2.29389524 |
| 63 | Depression (HP:0000716) | 2.28668451 |
| 64 | Ocular albinism (HP:0001107) | 2.28279971 |
| 65 | Abnormality of the periventricular white matter (HP:0002518) | 2.27402850 |
| 66 | Focal dystonia (HP:0004373) | 2.26787480 |
| 67 | Bradykinesia (HP:0002067) | 2.26145711 |
| 68 | Morphological abnormality of the inner ear (HP:0011390) | 2.25474214 |
| 69 | Foot dorsiflexor weakness (HP:0009027) | 2.25178878 |
| 70 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.24806402 |
| 71 | Aplasia of the phalanges of the hand (HP:0009802) | 2.24583245 |
| 72 | Aplasia involving bones of the extremities (HP:0009825) | 2.24583245 |
| 73 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.24583245 |
| 74 | Polyphagia (HP:0002591) | 2.24002010 |
| 75 | Type II lissencephaly (HP:0007260) | 2.23602516 |
| 76 | Hypoplastic pelvis (HP:0008839) | 2.23536114 |
| 77 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.23529428 |
| 78 | Hammertoe (HP:0001765) | 2.23373413 |
| 79 | Acute encephalopathy (HP:0006846) | 2.22334050 |
| 80 | Insomnia (HP:0100785) | 2.20774808 |
| 81 | Abnormal ciliary motility (HP:0012262) | 2.18990124 |
| 82 | Status epilepticus (HP:0002133) | 2.17374379 |
| 83 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.15988305 |
| 84 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.14843775 |
| 85 | Papilledema (HP:0001085) | 2.14392959 |
| 86 | Clonus (HP:0002169) | 2.14163702 |
| 87 | Postural tremor (HP:0002174) | 2.13411681 |
| 88 | Iris hypopigmentation (HP:0007730) | 2.13215129 |
| 89 | Anomalous pulmonary venous return (HP:0010772) | 2.12902845 |
| 90 | Progressive macrocephaly (HP:0004481) | 2.12395276 |
| 91 | Steppage gait (HP:0003376) | 2.12240277 |
| 92 | Dysdiadochokinesis (HP:0002075) | 2.11307135 |
| 93 | Methylmalonic acidemia (HP:0002912) | 2.09916050 |
| 94 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.09190427 |
| 95 | Apathy (HP:0000741) | 2.08922976 |
| 96 | Sleep apnea (HP:0010535) | 2.08673325 |
| 97 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.08075311 |
| 98 | Stridor (HP:0010307) | 2.07802579 |
| 99 | Decreased lacrimation (HP:0000633) | 2.07135186 |
| 100 | Choreoathetosis (HP:0001266) | 2.07131970 |
| 101 | Rapidly progressive (HP:0003678) | 2.05497394 |
| 102 | Craniofacial dystonia (HP:0012179) | 2.04963537 |
| 103 | Hemiparesis (HP:0001269) | 2.03945938 |
| 104 | Abnormality of the foot musculature (HP:0001436) | 2.03540808 |
| 105 | Spastic tetraparesis (HP:0001285) | 2.01068906 |
| 106 | Hypomagnesemia (HP:0002917) | 2.00070414 |
| 107 | Annular pancreas (HP:0001734) | 2.00031179 |
| 108 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.98587174 |
| 109 | Global brain atrophy (HP:0002283) | 1.98308355 |
| 110 | Megalencephaly (HP:0001355) | 1.98133345 |
| 111 | Decreased motor nerve conduction velocity (HP:0003431) | 1.98112869 |
| 112 | Epileptiform EEG discharges (HP:0011182) | 1.96150113 |
| 113 | Progressive cerebellar ataxia (HP:0002073) | 1.95837162 |
| 114 | Anteriorly placed anus (HP:0001545) | 1.95331297 |
| 115 | Alacrima (HP:0000522) | 1.95063987 |
| 116 | Hypokalemic alkalosis (HP:0001949) | 1.94863798 |
| 117 | Poor eye contact (HP:0000817) | 1.93400002 |
| 118 | Hypoplasia of the iris (HP:0007676) | 1.92838242 |
| 119 | CNS hypomyelination (HP:0003429) | 1.92564995 |
| 120 | Turricephaly (HP:0000262) | 1.89800371 |
| 121 | Absent septum pellucidum (HP:0001331) | 1.89455932 |
| 122 | Clumsiness (HP:0002312) | 1.88986019 |
| 123 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.88396438 |
| 124 | Neuronal loss in central nervous system (HP:0002529) | 1.87186365 |
| 125 | Epileptic encephalopathy (HP:0200134) | 1.87183888 |
| 126 | Diminished motivation (HP:0000745) | 1.87144940 |
| 127 | Gait ataxia (HP:0002066) | 1.86937991 |
| 128 | Focal seizures (HP:0007359) | 1.84461695 |
| 129 | Abnormality of saccadic eye movements (HP:0000570) | 1.82665459 |
| 130 | Gaze-evoked nystagmus (HP:0000640) | 1.80612743 |
| 131 | Partial agenesis of the corpus callosum (HP:0001338) | 1.80610757 |
| 132 | Split foot (HP:0001839) | 1.80118290 |
| 133 | Autoamputation (HP:0001218) | 1.79662178 |
| 134 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.79587480 |
| 135 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.78787965 |
| 136 | Urinary incontinence (HP:0000020) | 1.78062571 |
| 137 | Spastic paraparesis (HP:0002313) | 1.76883658 |
| 138 | Bowel incontinence (HP:0002607) | 1.76553039 |
| 139 | Abnormality of the pulmonary veins (HP:0011718) | 1.76466091 |
| 140 | Hepatosplenomegaly (HP:0001433) | 1.76090531 |
| 141 | Distal sensory impairment (HP:0002936) | 1.74866573 |
| 142 | Anxiety (HP:0000739) | 1.74544147 |
| 143 | Coronal craniosynostosis (HP:0004440) | 1.73970025 |
| 144 | Loss of speech (HP:0002371) | 1.72688317 |
| 145 | Spastic paraplegia (HP:0001258) | 1.72684295 |
| 146 | Hypophosphatemic rickets (HP:0004912) | 1.72591516 |
| 147 | Paraplegia (HP:0010550) | 1.70971357 |
| 148 | Abnormality of binocular vision (HP:0011514) | 1.70603930 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 5.58364541 |
| 2 | EPHB1 | 4.83348616 |
| 3 | MAPKAPK5 | 4.52392195 |
| 4 | OXSR1 | 3.06062454 |
| 5 | PBK | 2.98391970 |
| 6 | WNK4 | 2.61945153 |
| 7 | DAPK2 | 2.38996495 |
| 8 | UHMK1 | 2.33886167 |
| 9 | WNK1 | 2.21103904 |
| 10 | PNCK | 2.04149775 |
| 11 | PKN1 | 1.98985889 |
| 12 | TYRO3 | 1.84540784 |
| 13 | CAMKK1 | 1.83049354 |
| 14 | MST4 | 1.75284810 |
| 15 | SGK494 | 1.74870100 |
| 16 | SGK223 | 1.74870100 |
| 17 | CASK | 1.70390384 |
| 18 | RIPK1 | 1.70068558 |
| 19 | TNIK | 1.69900843 |
| 20 | NTRK1 | 1.61800762 |
| 21 | FGFR2 | 1.58370524 |
| 22 | TESK2 | 1.58301313 |
| 23 | LIMK1 | 1.46727018 |
| 24 | BCR | 1.45174200 |
| 25 | FES | 1.38196524 |
| 26 | MARK1 | 1.37903342 |
| 27 | ROCK2 | 1.29610319 |
| 28 | SGK2 | 1.23353185 |
| 29 | MUSK | 1.22237871 |
| 30 | NTRK3 | 1.17779051 |
| 31 | MINK1 | 1.15574205 |
| 32 | CAMK2B | 1.09212337 |
| 33 | MKNK1 | 1.08737935 |
| 34 | DYRK2 | 1.07710569 |
| 35 | CAMK1 | 1.06757568 |
| 36 | PAK6 | 1.05267103 |
| 37 | PHKG1 | 1.04835921 |
| 38 | PHKG2 | 1.04835921 |
| 39 | MAPK15 | 1.04065904 |
| 40 | MAP3K4 | 1.02570456 |
| 41 | MAP2K7 | 1.02126311 |
| 42 | PINK1 | 1.01865103 |
| 43 | RIPK4 | 1.01411968 |
| 44 | CLK1 | 1.00854823 |
| 45 | MAPK13 | 1.00541086 |
| 46 | CDK19 | 0.99493007 |
| 47 | MET | 0.99007472 |
| 48 | IRAK2 | 0.98799276 |
| 49 | MARK2 | 0.98413677 |
| 50 | CSNK1G3 | 0.96917844 |
| 51 | CAMK2D | 0.96650793 |
| 52 | MAP3K2 | 0.95843105 |
| 53 | NTRK2 | 0.90354108 |
| 54 | CAMK2A | 0.89967649 |
| 55 | CSNK1A1L | 0.89561739 |
| 56 | SGK3 | 0.89510738 |
| 57 | SGK1 | 0.89174618 |
| 58 | TNK2 | 0.88116244 |
| 59 | PRKD1 | 0.86672365 |
| 60 | NEK6 | 0.86120641 |
| 61 | KSR2 | 0.84772332 |
| 62 | MAP3K13 | 0.82970197 |
| 63 | FGR | 0.82752717 |
| 64 | MAPK10 | 0.82668574 |
| 65 | CDK5 | 0.82040066 |
| 66 | CAMK2G | 0.77258605 |
| 67 | CSNK1G2 | 0.77037277 |
| 68 | PRKCQ | 0.76090681 |
| 69 | EPHA4 | 0.75234138 |
| 70 | GRK5 | 0.74682599 |
| 71 | CSNK1G1 | 0.73796791 |
| 72 | PRKCE | 0.73009212 |
| 73 | GRK7 | 0.68162581 |
| 74 | DDR2 | 0.65977007 |
| 75 | CDK14 | 0.64815010 |
| 76 | PRKD3 | 0.64769412 |
| 77 | LMTK2 | 0.63204370 |
| 78 | IRAK1 | 0.63056079 |
| 79 | ALK | 0.62275317 |
| 80 | LATS2 | 0.61994213 |
| 81 | PDK2 | 0.61462007 |
| 82 | MAP2K2 | 0.60935002 |
| 83 | RPS6KA5 | 0.59460030 |
| 84 | RPS6KA3 | 0.59132525 |
| 85 | PAK3 | 0.58885992 |
| 86 | PLK2 | 0.58275633 |
| 87 | GSK3A | 0.57947934 |
| 88 | MAP3K9 | 0.57851197 |
| 89 | STK11 | 0.57289008 |
| 90 | PDPK1 | 0.57178920 |
| 91 | CDK15 | 0.57089127 |
| 92 | ERBB2 | 0.56530490 |
| 93 | PTK2B | 0.56303601 |
| 94 | FYN | 0.55346201 |
| 95 | CAMK1G | 0.53889208 |
| 96 | CDK18 | 0.53611056 |
| 97 | DAPK1 | 0.53329523 |
| 98 | DAPK3 | 0.53277827 |
| 99 | PRKCZ | 0.52529477 |
| 100 | STK38 | 0.51938459 |
| 101 | KSR1 | 0.49690352 |
| 102 | CDK11A | 0.49592797 |
| 103 | PRKG1 | 0.49450499 |
| 104 | PRKACB | 0.47005967 |
| 105 | ARAF | 0.46985393 |
| 106 | ADRBK2 | 0.46040158 |
| 107 | SIK2 | 0.45395822 |
| 108 | MAPK4 | 0.44617119 |
| 109 | PRKACA | 0.44328924 |
| 110 | MAPK12 | 0.43887619 |
| 111 | CSNK1A1 | 0.43391714 |
| 112 | DYRK1A | 0.42354758 |
| 113 | RAF1 | 0.42217523 |
| 114 | PRPF4B | 0.41497193 |
| 115 | PRKCA | 0.40596284 |
| 116 | CAMK4 | 0.40549071 |
| 117 | MOS | 0.40271040 |
| 118 | RET | 0.40202387 |
| 119 | PDGFRB | 0.39652610 |
| 120 | EPHA3 | 0.38147013 |
| 121 | MAP2K4 | 0.37153063 |
| 122 | SRC | 0.36356899 |
| 123 | PRKCG | 0.35129903 |
| 124 | CAMKK2 | 0.34789694 |
| 125 | PIK3CA | 0.34714634 |
| 126 | MAPK7 | 0.34110468 |
| 127 | PRKCH | 0.33044932 |
| 128 | CSNK1D | 0.32460009 |
| 129 | PDK1 | 0.32223224 |
| 130 | ROCK1 | 0.29892718 |
| 131 | INSR | 0.28974617 |
| 132 | BMPR2 | 0.28540152 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 5.84917833 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.93721218 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.56133147 |
| 4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.53107108 |
| 5 | Ether lipid metabolism_Homo sapiens_hsa00565 | 3.09565966 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.94862205 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.01954893 |
| 8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.91066457 |
| 9 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.80970956 |
| 10 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.68772006 |
| 11 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.63412712 |
| 12 | Parkinsons disease_Homo sapiens_hsa05012 | 1.58872128 |
| 13 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.57522704 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.52207763 |
| 15 | GABAergic synapse_Homo sapiens_hsa04727 | 1.50097888 |
| 16 | Alzheimers disease_Homo sapiens_hsa05010 | 1.49815476 |
| 17 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.44922748 |
| 18 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.44045310 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.43096100 |
| 20 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.42263645 |
| 21 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.38585414 |
| 22 | Protein export_Homo sapiens_hsa03060 | 1.35910969 |
| 23 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.34782698 |
| 24 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.28701806 |
| 25 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.27779086 |
| 26 | Bile secretion_Homo sapiens_hsa04976 | 1.26173410 |
| 27 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.24389028 |
| 28 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.23421610 |
| 29 | Long-term depression_Homo sapiens_hsa04730 | 1.23023598 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.17424018 |
| 31 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.13634421 |
| 32 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.08765721 |
| 33 | Circadian entrainment_Homo sapiens_hsa04713 | 1.08445620 |
| 34 | Morphine addiction_Homo sapiens_hsa05032 | 1.05913107 |
| 35 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.05234009 |
| 36 | Nicotine addiction_Homo sapiens_hsa05033 | 1.03371221 |
| 37 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.01914131 |
| 38 | Melanogenesis_Homo sapiens_hsa04916 | 1.01837342 |
| 39 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.01450078 |
| 40 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.99983281 |
| 41 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.99869955 |
| 42 | Axon guidance_Homo sapiens_hsa04360 | 0.97198697 |
| 43 | Glioma_Homo sapiens_hsa05214 | 0.95754835 |
| 44 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.94423313 |
| 45 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.94421230 |
| 46 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.94293397 |
| 47 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.91409381 |
| 48 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.91257345 |
| 49 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.90828899 |
| 50 | Salivary secretion_Homo sapiens_hsa04970 | 0.90788557 |
| 51 | Huntingtons disease_Homo sapiens_hsa05016 | 0.87086770 |
| 52 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.86928469 |
| 53 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.86446034 |
| 54 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.84842737 |
| 55 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.83730722 |
| 56 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.80605729 |
| 57 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.78493385 |
| 58 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.78435706 |
| 59 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.75779354 |
| 60 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.74027208 |
| 61 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.73853625 |
| 62 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.73490566 |
| 63 | Taste transduction_Homo sapiens_hsa04742 | 0.70245940 |
| 64 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.69353223 |
| 65 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.69334158 |
| 66 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.69289365 |
| 67 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.69247092 |
| 68 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.67996239 |
| 69 | Cocaine addiction_Homo sapiens_hsa05030 | 0.67606433 |
| 70 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.65641731 |
| 71 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.64304319 |
| 72 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.63578829 |
| 73 | Renin secretion_Homo sapiens_hsa04924 | 0.62802685 |
| 74 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.61903137 |
| 75 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.61459537 |
| 76 | Mineral absorption_Homo sapiens_hsa04978 | 0.61392193 |
| 77 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.60219738 |
| 78 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.59708693 |
| 79 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.59189355 |
| 80 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.58096499 |
| 81 | Long-term potentiation_Homo sapiens_hsa04720 | 0.56661004 |
| 82 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.56415165 |
| 83 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.55985856 |
| 84 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.55558790 |
| 85 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.55551340 |
| 86 | Prion diseases_Homo sapiens_hsa05020 | 0.55259427 |
| 87 | Circadian rhythm_Homo sapiens_hsa04710 | 0.55049057 |
| 88 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.54779729 |
| 89 | Olfactory transduction_Homo sapiens_hsa04740 | 0.54777497 |
| 90 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.54284231 |
| 91 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.53731798 |
| 92 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.53378218 |
| 93 | Gap junction_Homo sapiens_hsa04540 | 0.53278798 |
| 94 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.50023091 |
| 95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.49380631 |
| 96 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.49339002 |
| 97 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48178798 |
| 98 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47397441 |
| 99 | Insulin secretion_Homo sapiens_hsa04911 | 0.47125817 |
| 100 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.46961326 |
| 101 | Phototransduction_Homo sapiens_hsa04744 | 0.46473405 |
| 102 | Tight junction_Homo sapiens_hsa04530 | 0.45837258 |
| 103 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.45328420 |
| 104 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44418365 |
| 105 | Peroxisome_Homo sapiens_hsa04146 | 0.43677900 |
| 106 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.43523554 |
| 107 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.42682985 |
| 108 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.42149342 |
| 109 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.41327105 |
| 110 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.39113777 |
| 111 | Phagosome_Homo sapiens_hsa04145 | 0.38657480 |
| 112 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.38202046 |
| 113 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.37889566 |
| 114 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.37503874 |
| 115 | Endocytosis_Homo sapiens_hsa04144 | 0.37033967 |
| 116 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.36559118 |
| 117 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.36266508 |
| 118 | ABC transporters_Homo sapiens_hsa02010 | 0.35457708 |
| 119 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.34845469 |
| 120 | Metabolic pathways_Homo sapiens_hsa01100 | 0.34516004 |
| 121 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.33619417 |
| 122 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.33371097 |
| 123 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.31013150 |
| 124 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.30933626 |
| 125 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.30916717 |
| 126 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.30902672 |
| 127 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.30789953 |
| 128 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.30167955 |
| 129 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.29900264 |
| 130 | Lysosome_Homo sapiens_hsa04142 | 0.29624773 |
| 131 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.29222823 |
| 132 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.27958957 |

